Eisai Introduces New Individually-Wrapped Tabletsas as a New Addition of the Selbelle(R).Tokyo, Japan, July 17, 2007 - (JCN JCN Japan Corporate News JCN Journal of Cognitive Neuroscience JCN Journal of Cardiovascular Nursing JCN Journal of Christian Nursing JCN Job Control Number JCN Journal of Child Neurology JCN joint communications network (US DoD) Newswire) - Eisai Co., Ltd. today announced the launch of individually-wrapped tablets as a new addition of the Selbelle(R) Tablets, an OTC OTC See: Over-the-counter. OTC See over-the-counter market (OTC). (over-the-counter) product for gastric discomfort. The new product will be available in a twelve-dose box from July 18, 2007. Gastric symptoms such as stomach heaviness or heartburn heartburn, burning sensation beneath the breastbone, also called pyrosis. Heartburn does not indicate heart malfunction but results from nervous tension or overindulgence in food or drink. , are often induced when the amount of stomach mucus which protects the gastric mucosa gastric mucosa, n the lining of the stomach. from stomach acid decreases due to the influences from aging, poor physical condition, or irregular eating habits. Selbelle(R) relieves the stomach discomfort from repetitive stomach heaviness and heartburn by the effect of its active ingredient "Teprenone" that promotes the secretion of gastric mucus and protects gastric mucosa, as well as the natural extracts improving the function of gastric peristalsis peristalsis: see digestive system. peristalsis Progressive wavelike muscle contractions in the esophagus, stomach, and intestines, and sometimes in the ureters and other hollow tubes. . Selbelle(R) is the only OTC product that contains "Teprenone". Eisai launched Selbelle(R) (granule granule, in astronomy: see photosphere. formulation) in 2001 and Selbelle(R) Tablets in 2005. The new individually-wrapped tablets can be conveniently carried around by dose, which can help patients who need to take medication after meals outside of their homes and avoid missed dose. The tablets are also useful for taking to travels for treating gastric discomfort happens away from home. As the middle-aged population increases in Japan, the number of people who will experience repetitive stomach heaviness and heartburn is estimated to grow. The introduction of individually-wrapped tablets will strengthen Eisai's Selbelle[R] series to make further contributions to the benefits of middle-aged people suffering from stomach discomfort. For more information, please visit http://www.eisai.co.jp/enews/enews200726.html About Eisai Co., Ltd. Eisai Co., Ltd. (TSE See Tokyo Stock Exchange. TSE 1. See Tokyo Stock Exchange (TSE). 2. See Toronto Stock Exchange (TSE). : 4523; ADR ADR - Astra Digital Radio : ESALY) is a research-based human health care company that discovers, develops and markets products in more than 30 countries. Through a global network of research facilities, manufacturing sites and marketing subsidiaries, Eisai actively participates in all aspects of the worldwide health care system. Eisai employs more than 8,000 people worldwide. For more information, please visit http://www.eisai.co.jp. Source: Eisai Co., Ltd. Contact: Corporate Communications Department Eisai Co., Ltd. Tel: +81-3-3817-5036 Japan Corporate News Network. All rights reserved. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion